Protalix BioTherapeutics
PLX
#8929
Rank
NZ$0.28 B
Marketcap
NZ$3.51
Share price
4.06%
Change (1 day)
35.66%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03426. In 2024 the company made an earnings per share (EPS) of NZ$0.06852 a decrease over its 2023 EPS that were of NZ$0.21.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-61.15%
2024NZ$0.06852-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.53-50%
2021NZ-$1.06181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.11-31.67%
2018NZ-$3.08-72.31%
2017NZ-$11.13124.14%
2016NZ-$4.97-147.54%
2015NZ$10.45-290.62%
2014NZ-$5.486.67%
2013NZ-$5.14130.77%
2012NZ-$2.23-69.77%
2011NZ-$7.3719.44%
2010NZ-$6.17-12.2%
2009NZ-$7.0236.67%
2008NZ-$5.14-37.5%
2007NZ-$8.2250%
2006NZ-$5.483.23%
2005NZ-$5.31138.46%
2004NZ-$2.23-74%
2003NZ-$8.57-0%
2002NZ-$8.57-50%
2001NZ-$17.13233.33%
2000NZ-$5.14-84.21%
1999NZ-$32.55-24%
1998NZ-$42.83-600%
1997NZ$8.57-16.67%
1996NZ$10.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.24 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$11.49 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.19-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.35 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel